
Agilent Technologies A
€ 98.59
-0.31%
Quartalsbericht 2025-Q4
hinzugefügt 03.03.2026
Agilent Technologies EV 2011-2026 | A
EV Jährlich Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 45.8 B | 39.3 B | 28.7 B | 24.9 B | 23.2 B | 15.6 B | 15.2 B | 16.7 B | 15.8 B | 12.5 B | 10.5 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 45.8 B | 10.5 B | 22.6 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 1.63 | -1.52 % | $ 2.17 M | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Illumina
ILMN
|
15.3 B | $ 126.83 | -1.31 % | $ 20.2 B | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 24.61 | -1.48 % | $ 684 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 82.83 | -1.52 % | $ 5.59 B | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
National Research Corporation
NRC
|
432 M | $ 16.85 | -1.52 % | $ 377 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 22.39 | 2.47 % | $ 1.19 B | ||
|
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 27.06 | -1.74 % | $ 20 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Precipio
PRPO
|
42.5 M | $ 31.9 | 2.9 % | $ 51.2 M | ||
|
Personalis
PSNL
|
229 M | $ 5.43 | -8.89 % | $ 322 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Senseonics Holdings
SENS
|
376 M | $ 7.15 | -1.72 % | $ 298 M | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 15.19 | -2.63 % | $ 459 M | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Thermo Fisher Scientific
TMO
|
186 B | $ 470.48 | 0.52 % | $ 177 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 166.04 | -3.03 % | $ 8.23 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Trinity Biotech plc
TRIB
|
133 M | $ 0.63 | -2.99 % | $ 61.9 M | ||
|
Guardant Health
GH
|
15.2 B | $ 83.59 | -5.55 % | $ 10.5 B | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 59.97 | -1.7 % | $ 3.59 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 1.93 | - | $ 8.54 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 415.77 | -1.33 % | $ 12 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.19 | 0.23 % | $ 5.03 M | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 101.26 | -1.89 % | $ 8.35 B | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 260.26 | -1.2 % | $ 21.7 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.22 | -2.49 % | $ 2 B | ||
|
Celcuity
CELC
|
5.57 B | $ 120.71 | -3.95 % | $ 5.64 B | ||
|
NeoGenomics
NEO
|
1.85 B | $ 8.96 | 4.01 % | $ 1.15 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.88 | 1.04 % | $ 452 M | ||
|
Natera
NTRA
|
5.53 B | $ 202.48 | -0.93 % | $ 19.9 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 195.25 | -0.7 % | $ 21.7 B | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
OpGen
OPGN
|
10.3 M | - | -16.95 % | $ 1.54 M |